Cite
HARVARD Citation
Lipton, R. et al. (n.d.). P.010 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE II. Canadian journal of neurological sciences. p. S16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lipton, R. et al. (n.d.). P.010 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE II. Canadian journal of neurological sciences. p. S16. [Online].